IKK/IκB inhibitor MRT67307, Purity ≥98%

Cat. No.: X23-10-ZQ524

IKK/IκB inhibitor MRT67307, Purity ≥98%

Synonym: MRT67307; 1190378-57-4; MRT-67307; MEY37JZ4XR; N-[3-[[5-Cyclopropyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]propyl]cyclobutanecarboxamide; UNII-MEY37JZ4XR; IKK/IκB inhibitor

  • CAS Number: 1190378-57-4
  • Compound CID: 44464263
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MRT67307, soluble in warmed DMSO, water and ethanol, modulates IKK-IκB signaling pathway, which plays a key role in inflammation and immune responses. It targets Autophagy, IKKε, TBK1, ULK1, and ULK2.
Molecular Weight
464.6
Molecular Formula
C26H36N6O2
Targets
Autophagy; IKKε: 160 nM (At 0.1 mM ATP); TBK1: 19 nM (At 0.1 mM ATP); ULK1: 45 nM; ULK2: 38 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 87 mg/mL; Water: 87 mg/mL; Ethanol: 87 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
MRT67307 can be used to investigate the inhibition of IκB kinase and its role in NF-κB pathway signaling.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.